Angiotech Pharmaceuticals
| Public | |
| Industry | Pharmaceutical |
| Headquarters | Vancouver, British Columbia, Canada |
Key people | K. Thomas Bailey |
Number of employees | 1450[1] |
| Website | www.angiotech.com |
Angiotech is a Vancouver, British Columbia pharmaceutical company. Its products enhance the performance of medical devices and biomaterials through the use of pharmacotherapeutics. Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury.
In April 2010, Angiotech acquired Haemacure manufacturing to develop human biological adhesives, hemostats and therapeutic proteins.
Angiotech, based in Vancouver, British Columbia, was founded in 1992 by William L. Hunter, M.D., Lindsay Machan, M.D., and Larry Arsenault, Ph.D.
References
- ↑ "Company Profile for Angiotech Pharmaceuticals Inc (CA;ANP)". Retrieved 2008-10-10.
External links
This article is issued from Wikipedia - version of the Sunday, September 13, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.